Nasdaq
$0.4100▼ 0.36%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $3.2MShares out 7.7M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
45- 2d agoAfter-hours26.10.23 06:298-KKey event#●●●#●●●#●●●
Glucotrack, Inc.Bullish
On October 22, 2026, Glucotrack, Inc. completed a financing transaction by issuing senior secured convertible promissory notes with an aggregate principal amount of $2,564,102.65 for $2,000,000 in gross proceeds, along with warrants to purchase 8,025,360 shares of common stock. The notes include a 22% original issue discount, and the company is required to seek stockholder approval to increase the exchange cap for the underlying shares.…more
$0.4100-0.36%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 5d agoAfter-hours26.10.20 05:058-KKey event
Glucotrack, Inc.
Glucotrack has entered into a waiver agreement with existing warrant holders to terminate restrictions on equity issuances and variable rate transaction price adjustments in exchange for the issuance of new warrants to purchase 406,198 shares. The new warrants have an exercise price of $7.50 per share and are exercisable subject to shareholder approval. This agreement provides the company with greater flexibility for future financing and capital structure adjustments.…more
$0.4100-0.36%vs prev closeView filingShare - 10.14Regular26.10.14 23:02PRE 14AOther
Glucotrack, Inc.
Glucotrack, Inc. has called a special meeting of stockholders to approve the issuance of common stock related to its September financing, specifically to comply with Nasdaq Listing Rule 5635(d). Additionally, the company is seeking shareholder approval for a reverse stock split of its common stock at a ratio not to exceed 1-for-[ ] to maintain listing compliance. Shareholders are urged to vote on these proposals to authorize the full conversion and exercise of previously issued notes and warrants.…more
$0.4100-0.36%vs prev closeView filingShare
44 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 1d agoAfter-hours26.10.24 08:50
Trading Halt: News Pending
Trading of the stock was halted at 7:50 p.m. ET pending the release of material news. Investors should monitor upcoming announcements as they may significantly impact the stock price.…more
$0.4100-0.36%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 2d agoPre-market26.10.22 22:04
●●●●●●●● ●●●●● ●●●●●●
Glucotrack will implement a 1-for-2 reverse stock split starting October 26 to meet listing requirements. This action reduces the number of outstanding shares and is a common move for companies facing low share prices.…more
$0.4100-0.36%vs prev closeShareBenzinga - 9.30Pre-market26.09.30 22:09
●●●●●●●● ●●●●● ●●●●●●
Glucotrack's subsidiary, Lōkahi Therapeutics, has introduced Qare, a platform designed to help GLP-1 medication users compare their treatment experiences with others. The platform is scheduled for public release on October 14, 2026, aiming to improve transparency in patient-driven health data.…more
$0.4100-0.36%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report